Feb 14 Johnson & Johnson, the subject of
thousands of lawsuits stemming from the 2010 recall of its ASR
all-metal hip implants, last month recalled a second type of
metal hip component that it sold outside of the United States.
J&J's DePuy unit told doctors in January that the Adept
modular heads, a component used with its Adept metal-on-metal
hip replacement device, should not be used after data showed
that the devices were failing at a higher than expected rate,
according to an emailed statement.
The email said British data showed that the Adept implants
needed to be replaced in about 12 percent of patients after
seven years. An Australian patient registry showed a revision
rate of 7 percent after three years.
The company said it sold around 7,500 of the hip components
between 2004 to September 2011. They were sold in 21 countries,
but not in the United States.
In August 2010, J&J recalled two types of its ASR
metal-on-metal hip implants after they were also linked to high
Some 93,000 of the ASR hips were sold prior to the recall,
which has generated more than 10,000 lawsuits. The first suit,
brought by a retired Montana prison guard who says the hip
caused metal poisoning, is currently being heard in a Los
Angeles Superior Court.
J&J has set aside more than $3 billion to cover costs for
the ASR hip recall. The company over the past couple of years
has also had to recall over-the-counter drugs, contact lenses,
heart devices, such as stents, and insulin pump cartridges.